BOYLE SCOTT N (Chief Business Officer) sold 1.1% of their position (1.16K shares) of C4 THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/18/2025ACC: 0001662579-25-000019
Officer· Chief Business Officer
Since Mar 2022
+135.94K
Net shares
Net buyer
$16.7K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
141.20K acquired · 5.26K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
−1.74K
Price / share
$3.20
Trade value
$5.55K
% of position
3.1%
2/13/2025
56.57K→54.83K
Common Stock
Direct
Shares
+56.50K
Price / share
—
Trade value
—
% of position
103.0%
2/14/2025
54.83K→111.33K
Common Stock
Direct
Shares
−490.00
Price / share
$3.15
Trade value
$1.54K
% of position
0.4%
2/14/2025
111.33K→110.84K
Common Stock
Direct
Shares
−2.37K
Price / share
$3.18
Trade value
$7.53K
% of position
2.1%
2/14/2025
110.84K→108.47K
Common Stock
Direct
Shares
−669.00
Price / share
$3.15
Trade value
$2.11K
% of position
0.6%
2/18/2025
108.47K→107.81K
Total
Net shares
+51.24K
Net value
-$16.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2025 | F · Tax Withholding | −1.74K | $3.20 | $5.55K | 3.1% | 56.57K | 54.83K |
| Common Stock Direct | 2/14/2025 | A · Award | +56.50K | — | — | 103.0% | 54.83K | 111.33K |
| Common Stock Direct | 2/14/2025 | S · Sale | −490.00 | $3.15 | $1.54K | 0.4% | 111.33K | 110.84K |
| Common Stock Direct | 2/14/2025 | F · Tax Withholding | −2.37K | $3.18 | $7.53K | 2.1% | 110.84K | 108.47K |
| Common Stock Direct | 2/18/2025 | S · Sale | −669.00 | $3.15 | $2.11K | 0.6% | 108.47K | 107.81K |
| Total | +51.24K | -$16.73K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
84.70K shares
Shares
+84.70K
Strike price
3.18
Held after
84.70K
Exercisable
—
2/14/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock84.70K shares | 2/14/2025 | A · Award | +84.70K | 3.18 | — | 84.70K |